Delcath Systems, Inc. (NASDAQ:DCTH – Get Free Report) shares rose 9.3% during trading on Monday . The stock traded as high as $16.46 and last traded at $16.51. 1,011,482 shares traded hands during trading, an increase of 113% from the average daily volume of 475,969 shares. The stock had previously closed at $15.11.
Analyst Ratings Changes
A number of brokerages recently issued reports on DCTH. Zacks Research upgraded shares of Delcath Systems from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 7th. Weiss Ratings reissued a “sell (d+)” rating on shares of Delcath Systems in a research report on Friday. HC Wainwright restated a “buy” rating and issued a $32.00 price objective (up from $30.00) on shares of Delcath Systems in a report on Friday. Wall Street Zen raised shares of Delcath Systems from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, BTIG Research boosted their target price on shares of Delcath Systems from $17.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Delcath Systems currently has an average rating of “Moderate Buy” and an average target price of $23.17.
Check Out Our Latest Analysis on Delcath Systems
Delcath Systems Stock Performance
Delcath Systems (NASDAQ:DCTH – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.16. The business had revenue of $29.13 million during the quarter, compared to analysts’ expectations of $26.25 million. Delcath Systems had a return on equity of 0.46% and a net margin of 0.56%. On average, sell-side analysts predict that Delcath Systems, Inc. will post -0.88 EPS for the current fiscal year.
Institutional Investors Weigh In On Delcath Systems
A number of large investors have recently bought and sold shares of DCTH. Deutsche Bank AG raised its position in shares of Delcath Systems by 5.4% during the fourth quarter. Deutsche Bank AG now owns 24,162 shares of the company’s stock worth $244,000 after purchasing an additional 1,248 shares during the period. California State Teachers Retirement System acquired a new position in shares of Delcath Systems in the 2nd quarter valued at $26,000. Intech Investment Management LLC boosted its position in shares of Delcath Systems by 13.1% in the 4th quarter. Intech Investment Management LLC now owns 17,595 shares of the company’s stock valued at $178,000 after purchasing an additional 2,035 shares during the period. AWM Investment Company Inc. increased its stake in Delcath Systems by 3.9% in the 4th quarter. AWM Investment Company Inc. now owns 60,000 shares of the company’s stock worth $606,000 after purchasing an additional 2,279 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in Delcath Systems by 14.8% in the 1st quarter. Royal Bank of Canada now owns 18,383 shares of the company’s stock worth $170,000 after purchasing an additional 2,364 shares in the last quarter. Institutional investors and hedge funds own 61.12% of the company’s stock.
Delcath Systems Company Profile
Delcath Systems, Inc is a specialty pharmaceutical and medical technology company focused on the development and commercialization of its proprietary Hepatic CHEMOSAT® Delivery System, designed to deliver high-dose chemotherapeutic agents directly to the liver while minimizing systemic exposure. The company’s core technology performs isolated hepatic perfusion, enabling oncologists to administer concentrated melphalan to patients with primary and metastatic liver tumors, including those arising from ocular melanoma.
Featured Articles
- Five stocks we like better than Delcath Systems
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Delcath Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems and related companies with MarketBeat.com's FREE daily email newsletter.
